Desq Long
Sign in
SEC FORM 4
$2,893,886.82

BridgeBio Pharma, Inc. (BBIO)

Disposition (code F) of 36,237 shares at $79.86 per share.

Reporting Person Kumar Neil · Officer Title Chief Executive Officer · Transaction Code F

Traded Aug 16, 2026 · Disclosed Aug 18, 2026

Source: SEC Form 4 · 0001470831-26-000836 · filed 2026-08-18 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "BridgeBio Pharma, Inc. (BBIO)." Disclosed 2026-08-18. https://desqlong.com/cards/0001470831-26-000836-5 (retrieved 2026-09-26).